10th Antifibrotic Drug Development Summit

1–3 December 2026 · Boston, Massachusetts, United States · Conference · 31 views

No separate submission deadline recorded. The organiser lists the same date for submissions and the event, so check their site for the real cut-off.

Conference details

  • StartsTuesday, 1 December 2026
  • EndsThursday, 3 December 2026
  • Location Boston, Massachusetts, United States
  • FormatConference
  • OrganiserHanson Wade
  • ContactEden Chau — info@hansonwade.com
  • Official site afdd-summit.com/
  • Verification Unverified We could not confirm this listing. Verify before paying.

About this conference

From Exploring Shared Fibrosis Biology and Resolution Mechanisms to Evaluating Human-Relevant Models and Predictive Biomarkers: Navigate Cross-Indication Expansion with Confidence. Time: 8:00 AM - 6:00 PM. Prices: USD 2699.00 - USD 5297.00.

Highlights

10th Antifibrotic Drug Development Summit 2026
Join fibrosis experts in Boston to explore biomarkers, models and next-generation antifibrotic therapies.

Celebrate Our 10th Anniversary at the Premier Antifibrotic Summit
From Exploring Shared Fibrosis Biology & Resolution Mechanisms to Evaluating Human-Relevant Models & Predictive Biomarkers: Navigate Cross-Indication Expansion with Confidence
With Celea Therapeutics raising $180 million towards its Phase 3 IPF program, GRI Bio securing FDA Orphan Drug Designation and multiple differentiated assets advancing through clinical development, confidence in next-generation antifibrotic therapies continues to build. At the same time, advances in single-cell sequencing, spatial transcriptomics, human tissue models, and predictive biomarkers are giving developers a more precise view of the cell states, tissue niches, and pathways driving fibrosis.
Yet fibrosis is not one disease. Different organs begin with different injuries and microenvironments, while many programs converge around shared processes. Understanding where these mechanisms are truly conserved, where tissue-specific biology changes the strategy, and which lessons can be transferred from one indication to another is becoming increasingly important for target selection, model design, biomarker development, and indication expansion.
Returning to Boston for its landmark 10th anniversary , the Antifibrotic Drug Development Summit is the only industry-focused forum dedicated to cross-indication antifibrotic drug development, uniting 60+ senior leaders across discovery , preclinical , translational , biomarker, and early clinical development .

Getting there

Boston, Massachusetts, United States. Open in Google Maps

Details are supplied by the organiser or collected from public sources. Confirm dates, fees and submission requirements on the official site before you travel or pay. No conference can guarantee Scopus or Web of Science indexing in advance — proceedings are assessed after publication. How to spot a predatory conference.

Never miss a deadline in United States

One email a week with conferences in your field, plus a reminder before each window closes.